We previously found that HBL patients have an elevated ph-S675-β-catenin pathway [10], which increases the expression of HDAC1 and Sp5, leading to the repression of two families of proteins: Cytochromes (CYPs) and Solute Carrier (SLC) transporters [28]. The gene discussed is SP5; the disease is hepatoblastoma.